Method of using α-amylase from Aspergillus clavatus for saccharification
US-9365871-B2 · Jun 14, 2016 · US
US9765374B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9765374-B2 |
| Application number | US-201314649173-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 5, 2013 |
| Priority date | Dec 14, 2012 |
| Publication date | Sep 19, 2017 |
| Grant date | Sep 19, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A fungal alpha-amylase is provided from Aspergillus fumigatus (AfAmyl). AfAmyl has an optimal pH of 3.5 and is operable at 30-75 degrees C., allowing the enzyme to be used in combination with a glucoamylase and an isoamylase in a saccharification reaction. This obviates the necessity of running a saccharification reaction as a batch process, where the pH and temperature must be readjusted for optimal use of the alpha-amylase or glucoamylase. AfAmyl also catalyzes the saccharification of starch substrates to an oligosaccharide composition significantly enriched in DP2 and (DPI+DP2) compared to the products of saccharification catalyzed by an alpha-amylase from Aspergillus kawachii . This facilitates the utilization of the oligosaccharide composition by a fermenting organism in a simultaneous saccharification and fermentation process, for example.
Opening claim text (preview).
What is claimed is: 1. A method of saccharifying a composition comprising starch to produce a composition comprising glucose, wherein said method comprises: (i) contacting said composition comprising starch with an isoamylase and an isolated AfAmyl or variant thereof having α-amylase activity comprising an amino acid sequence with at least 80% amino acid sequence identity to (a) residues 24-630 of SEQ ID NO:1 or (b) residues 24-502 of SEQ ID NO:1; and (ii) saccharifying said composition comprising starch to produce said composition comprising glucose; wherein said isoamylase and said isolated AfAmyl or variant thereof catalyze the saccharification of the starch composition to glucose wherein the AfAmyl or variant thereof is dosed at 17%-50% the dose of AkAA, to reduce the same quantity of residual starch under the same conditions, and wherein the saccharification results in 2%-11% less residual starch compared to a saccharification carried out by said isoamylase and AkAA under the same conditions. 2. The method of claim 1 , wherein the AfAmyl or variant thereof is dosed at about 17%-50% the dose of AkAA, to reduce the same quantity of DP3+ under the same conditions. 3. The method of claim 1 , wherein said composition comprising glucose is enriched in DP2 or (DP1+DP2), compared to a second composition comprising glucose produced by AkAA with said isoamylase under the same conditions. 4. The method of claim 1 , wherein the AfAmyl or variant thereof is dosed at about 33% the dose of AfAmyl that would be required to reduce the same quantity of residual starch under the same conditions in the absence of isoamylase, and optionally, wherein said isoamylase is dosed at about 13% the dose of AfAmyl that would be required to reduce the same quantity of residual starch under the same conditions in the absence of isoamylase. 5. The method of claim 1 , wherein the AfAmyl or variant thereof is dosed at about 50% the dose of AfAmyl that would be required to reduce the same quantity of DP3+ under the same conditions in the absence of isoamylase, and optionally, wherein said isoamylase is dosed at about 9% the dose of AfAmyl that would be required to reduce the same quantity of DP3+ under the same conditions in the absence of isoamylase. 6. The method of claim 1 , wherein the AfAmyl or variant thereof is dosed at about 33% the dose of AfAmyl that would be required to produce the same ethanol yield under the same conditions in the absence of isoamylase, and optionally, wherein said isoamylase is dosed at about 6.3% the dose of AfAmyl that would be required to produce the same ethanol yield under the same conditions in the absence of isoamylase. 7. The method of claim 1 , wherein said AfAmyl or variant thereof comprises an amino acid sequence with at least 90%, 95%, or 99% amino acid sequence identity to (a) residues 24-630 of SEQ ID NO:1 or (b) residues 24-502 of SEQ ID NO:1. 8. The method of claim 7 , wherein said AfAmyl or variant thereof comprises (a) residues 24-630 of SEQ ID NO:1 or (b) residues 24-502 of SEQ ID NO:1. 9. The method of claim 1 , wherein said AfAmyl or variant thereof consists of an amino acid sequence with at least 80%, 90%, 95%, or 99% amino acid sequence identity to (a) residues 24-630 of SEQ ID NO:1 or (b) residues 24-502 of SEQ ID NO:1. 10. The method of claim 9 , wherein said AfAmyl or variant thereof consists of (a) residues 24-630 of SEQ ID NO:1 or (b) residues 24-502 of SEQ ID NO:1. 11. The method of claim 1 , further comprising fermenting the glucose composition to produce an End of Fermentation (EOF) product. 12. The method of claim 11 , wherein said fermentation is a simultaneous saccharification and fermentation (SSF) reaction. 13. A method of producing a fermented beverage, comprising (i) contacting said composition comprising starch with an isoamylase and an isolated AfAmyl or variant thereof having α-amylase activity comprising an amino acid sequence with at least 80% amino acid sequence identity to (a) residues 24-630 of SEQ ID NO:1 or (b) residues 24-502 of SEQ ID NO:1; and (ii) saccharifying said composition comprising starch to produce said composition comprising glucose; wherein said isoamylase and said isolated AfAmyl or variant thereof catalyze the saccharification of the starch composition to glucose wherein the AfAmyl or variant thereof is dosed at 17%-50% the dose of AkAA, to reduce the same quantity of residual starch under the same conditions, and wherein the saccharification results in 2%-11% less residual starch compared to a saccharification carried out by said isoamylase and AkAA under the same conditions. 14. The method of claim 1 , further comprising adding glucoamylase, hexokinase, xylanase, glucose isomerase, xylose isomerase, phosphatase, phytase, protease, pullulanase, β-amylase, α-amylase, protease, cellulase, hemicellulase, lipase, cutinase, trehalase, redox enzyme, esterase, transferase, pectinase, alpha-glucosidase, beta-glucosidase, lyase, hydrolase, branching enzyme, or a combination thereof, to said starch composition. 15. The method of claim 1 , wherein said isolated AfAmyl or a variant thereof is expressed and secreted by a host cell. 16. The method of claim 15 , wherein said host cell further expresses and secretes said isoamylase. 17. The method of claim 15 , wherein said composition comprising starch is contacted with said host cell. 18. The method of claim 15 , wherein said host cell further expresses and secretes a glucoamylase. 19. The method of claim 15 , wherein the host cell is capable of fermenting the glucose composition.
Related publications grouped by family.
Answers are generated from the same data shown on this page.